ClinicalTrials.Veeva

Menu

Inappropriate Prescribing in the Elderly (STOPP&START)

R

Regione del Veneto - AULSS n. 7 Pedemontana

Status

Completed

Conditions

Hospitalized
Elderly (people Aged 65 or More)
Prevalence
Prescriptions

Study type

Observational

Funder types

Other

Identifiers

NCT06760728
571CESC

Details and patient eligibility

About

The management of pharmacotherapy in elderly patients is an increasingly critical aspect, as polypharmacy, combined with the pharmacokinetic and pharmacodynamic changes typical of aging, makes older adults more sensitive to the development of adverse reactions. This highlights the importance of appropriate use of pharmacotherapy that considers the risks and benefits of individual treatments. The aim of this study is to measure the prevalence of pharmacological appropriateness using the STOPP/START criteria (version 2) at admission and discharge from an acute geriatric ward, thereby evaluating the impact of hospitalization on medication prescribing.

Enrollment

100 patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged ≥ 70 years admitted to a geriatric ward
  • Regardless of ethnicity, gender, or type of illness
  • Patients transferred from another ward
  • Patients admitted to another ward for support

Exclusion criteria

• Patients in the terminal phase (<6 months life expectancy)

Criteria for exit from the study (Dropout):

  • Patients transferred to another hospital ward
  • Patients who have deceased

Trial design

100 participants in 1 patient group

STOPP/START Team
Description:
Patients over 70 years old admitted to a geriatric ward, regardless of ethnicity, gender, or type of illness, will be considered eligible for enrollment. Patients transferred from another ward or admitted on a support basis to another ward will also be considered eligible.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems